AV

Avoro Ventures

North America, New York, United States, New York

Description

Avoro Ventures is an investment firm that manages biopharma venture funds.

Investor Profile

Avoro Ventures has made 5 investments, with 1 in the past 12 months and 20% as lead.

Stage Focus

  • Series B (80%)
  • Post Ipo Equity (20%)

Country Focus

  • United States (60%)
  • Denmark (20%)
  • United Kingdom (20%)

Industry Focus

  • Biotechnology
  • Life Science
  • Medical
  • Biopharma
  • Oncology
  • Health Care
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Avoro Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Co-Investments: 1
AC
North America, California, United States, Belmont
Co-Investments: 1
RTW Investments
North America, New York, United States, New York
Co-Investments: 1
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Co-Investments: 1
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 2
Avoro Capital Advisors
North America, New York, United States, New York
Co-Investments: 2
Acorn Bioventures
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Avoro Ventures?

Vicebio

London, England, United Kingdom

Vicebio is committed to employing the Molecular Clamp Technology to create vaccines against next-generation respiratory viruses.

BiotechnologyMedical
Series BSep 23, 2024
Amount Raised: $100,000,000
Hemab

Copenhagen, Hovedstaden, Denmark

Hemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.

BiotechnologyLife SciencePharmaceutical
Series BFeb 21, 2023
Amount Raised: $135,000,000
Vanqua Bio

Chicago, Illinois, United States

Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.

BiotechnologyHealth CareMedical
Series BSep 14, 2021
Amount Raised: $85,000,000
Aadi Bioscience

Pacific Palisades, California, United States

Aadi Bioscience develops a potentially mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases.

BiopharmaBiotechnologyLife ScienceOncology
Post Ipo EquityAug 26, 2021
Amount Raised: $154,999,876
Scribe Therapeutics

Alameda, California, United States

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

BiotechnologyLife ScienceTherapeutics
Series BMar 31, 2021
Amount Raised: $100,000,000